Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin

Experimental Dermatology

Volumn 23, Issue 5, 2014, Pages 326-331

  Do, Nhung ^a   Weindl, Günther ^a   Grohmann, Lisa ^a   Salwiczek, Mario ^a   Koksch, Beate ^a   Korting, Hans Christian ^b   Schäfer Korting, Monika ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antimicrobial peptides; Candida albicans; Cell penetrating peptides; Skin penetration; Squamous cell carcinoma

Indexed keywords

AMPHOTERICIN B; CECROPIN A; CELL PENETRATING PEPTIDE; FLUOROURACIL; HISTATIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LOW MOLECULAR WEIGHT PROTAMINE; MELITTIN; PENETRATIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTAMINE; PROTEGRIN 1; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; PEPTIDE;

ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHILICITY; IC 50; KERATINOCYTE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; SKIN CANCER; SKIN FIBROBLAST; SKIN PENETRATION; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; SKIN; SKIN NEOPLASMS; TUMOR CELL LINE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; CANDIDA ALBICANS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROURACIL; HUMANS; KERATINOCYTES; MELITTEN; PEPTIDES; PROTAMINES; SKIN; SKIN NEOPLASMS;

EID: 84899523048     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12384     Document Type: Article

References (62)

1. Scola N, Gambichler T, Saklaoui H et al. Br J Dermatol 2012: 167: 591-597.
2. Schröder J M, Harder J. Cell Mol Life Sci 2006: 63: 469-486.
3. Nakatsuji T, Gallo R L. J Invest Dermatol 2012: 132: 887-895.
4. Gallo R L, Nakatsuji T. J Invest Dermatol 2011: 131: 1974-1980.
5. Harder J, Schröder J M, Gläser R. Exp Dermatol 2013: 22: 1-5.
6. Hancock R E. Lancet Infect Dis 2001: 1: 156-164.
7. Hoskin D W, Ramamoorthy A. Biochim Biophys Acta 2008: 1778: 357-375.
8. Zasloff M. Nature 2002: 415: 389-395.
9. Mehra T, Köberle M, Braunsdorf C et al. Exp Dermatol 2012: 21: 778-782.
10. Mader J S, Hoskin D W. Expert Opin Investig Drugs 2006: 15: 933-946.
11. Maher S, McClean S. Biochem Pharmacol 2008: 75: 1104-1114.
12. Suttmann H, Retz M, Paulsen F et al. BMC Urol 2008: 8: 5.
13. Ceron J M, Contreras-Moreno J, Puertollano E et al. Peptides 2010: 31: 1494-1503.
14. Weston K M, Raison R L. J Cell Biochem 1998: 68: 164-173.
15. Liu S, Yu M, He Y et al. Hepatology 2008: 47: 1964-1973.
16. Kokryakov V N, Harwig S S L, Panyutich E A et al. FEBS Lett 1993: 327: 231-236.
17. Raj P A, Edgerton M, Levine M J. J Biol Chem 1990: 265: 3898-3905.
18. Desai P, Patlolla R R, Singh M. Mol Membr Biol 2010: 27: 247-259.
19. Schäfer-Korting M, Bock U, Diembeck W et al. Altern Lab Anim 2008: 36: 161-187.
20. Huang Y, Park Y S, Moon C et al. Angew Chem Int Ed Engl 2010: 49: 2724-2727.
21. Hsu T, Mitragotri S. Proc Natl Acad Sci U S A 2011: 108: 15816-15821.
22. Steinsträsser I, Merkle H P. Pharm Acta Helv 1995: 70: 3-24.
23. Ogiso T, Iwaki M, Tanino T et al. Biol Pharm Bull 2000: 23: 1346-1351.
24. Henriques S T, Melo M N, Castanho M A. Biochem J 2006: 399: 1-7.
25. Splith K, Neundorf I. Eur Biophys J 2011: 40: 387-397.
26. Heitz F, Morris M C, Divita G. Br J Pharmacol 2009: 157: 195-206.
27. Wadia J S, Dowdy S F. Curr Opin Biotechnol 2002: 13: 52-56.
28. Park Y J, Chang L C, Liang J F et al. FASEB J 2005: 19: 1555-1557.
29. Derossi D, Joliot A H, Chassaing G et al. J Biol Chem 1994: 269: 10444-10450.
30. Höltje M, Richartz A, Zdrazil B et al. J Enzyme Inhib Med Chem 2010: 25: 250-265.
31. Chou T C. Cancer Res 2010: 70: 440-446.
32. Chou T C. Pharmacol Rev 2006: 58: 621-681.
33. Schäfer-Korting M, Bock U, Gamer A et al. Altern Lab Anim 2006: 34: 283-294.
34. Bätz F M, Klipper W, Korting H C et al. Eur J Pharm Biopharm 2013: 84: 374-385.
35. DeLucca A J, Bland J M, Jacks T J et al. Antimicrob Agents Chemother 1997: 41: 481-483.
36. Park C, Lee D G. Biochem Biophys Res Commun 2010: 394: 170-172.
37. Korting H C, Schäfer-Korting M. Handb Exp Pharmacol 2010: 197: 435-468.
38. Dombrowski Y, Peric M, Koglin S et al. Allergy 2012: 67: 1400-1407.
39. Sommer A, Fries A, Cornelsen I et al. J Biol Chem 2012: 287: 23678-23689.
40. Jo M, Park M H, Kollipara P S et al. Toxicol Appl Pharmacol 2012: 258: 72-81.
41. Korting H C, Schöllmann C, Stauss-Grabo M et al. Skin Pharmacol Physiol 2012: 25: 323-334.
42. Kundu S, Fan K, Cao M et al. Mol Cancer Ther 2010: 9: 2287-2296.
43. Vazquez J A. Future Microbiol 2007: 2: 115-139.
44. Giamarellou H, Poulakou G. Drugs 2009: 69: 1879-1901.
45. Hui L, Leung K, Chen H M. Anticancer Res 2002: 22: 2811-2816.
46. Shai Y. Biochim Biophys Acta 1999: 1462: 55-70.
47. Lee M T, Sun T L, Hung W C et al. Proc Natl Acad Sci U S A 2013: 110: 14243-14248.
48. Moon D O, Park S Y, Choi Y H et al. Toxicon 2008: 51: 112-120.
49. Gajski G, Garaj-Vrhovac V. Environ Toxicol Pharmacol 2013: 36: 697-705.
50. Brogden K A. Nat Rev Microbiol 2005: 3: 238-250.
51. Benincasa M, Scocchi M, Pacor S et al. J Antimicrob Chemother 2006: 58: 950-959.
52. Matsuzaki K. Biochim Biophys Acta 2009: 1788: 1687-1692.
53. Nasrollahi S A, Taghibiglou C, Azizi E et al. Chem Biol Drug Des 2012: 80: 639-646.
54. Lee J, Jung E, Park J et al. Biotechnol Appl Biochem 2005: 42: 169-173.
55. Lee J H, Bae I H, Choi J K et al. J Pharm Sci 2013: 102: 4109-4120.
56. Lopes L B, Furnish E, Komalavilas P et al. Eur J Pharm Biopharm 2008: 68: 441-445.
57. Boderke P, Merkle H P, Cullander C et al. J Invest Dermatol 1997: 108: 83-86.
58. Rothbard J B, Garlington S, Lin Q et al. Nat Med 2000: 6: 1253-1257.
59. Futaki S, Suzuki T, Ohashi W et al. J Biol Chem 2001: 276: 5836-5840.
60. Mitchell D J, Steinman L, Kim D T et al. J Pept Res 2000: 56: 318-325.
61. Tréhin R, Nielsen H M, Jahnke H G et al. Biochem J 2004: 382: 945-956.
62. Fjell C D, Hiss J A, Hancock R E et al. Nat Rev Drug Discov 2012: 11: 37-51.